AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹47 Cr | ₹-201 Cr | ₹124 Cr | ₹28 Cr | ₹-24 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AJANTA PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹47 Cr |
Mar2024 | ₹-201 Cr |
Mar2023 | ₹124 Cr |
Mar2022 | ₹28 Cr |
Mar2021 | ₹-24 Cr |
How is Net Cash Inflow / Outflow of AJANTA PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹47 Cr | Positive | |
Mar2024 | ₹-201 Cr | Negative | |
Mar2023 | ₹124 Cr | 345.56 | |
Mar2022 | ₹28 Cr | Positive | |
Mar2021 | ₹-24 Cr | - |
Compare Net Cash Inflow / Outflow of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹33,566.3 Cr | 4.4% | 4.4% | 17.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,284.0 Cr | -0% | -0.4% | 10.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹183,268.0 Cr | 1.4% | 4.1% | 50.3% | Stock Analytics | |
CIPLA | ₹122,253.0 Cr | 0.5% | 1.6% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,988.0 Cr | -1.2% | 7.1% | 18.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,921.0 Cr | 1.7% | 1.2% | 1.5% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | 4.4% |
4.4% |
17.4% |
SENSEX | -0.7% |
3% |
5% |
You may also like the below Video Courses